Clinical Trial Update: OssiMend BA in Posterolateral Instrumented Lumbar Fusion

View source ↗

Summary

Clinical trial update for OssiMend BA in posterolateral instrumented lumbar fusion shows the study is currently recruiting for spinal disease and degenerative d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Disease

Drugs mentioned

• OssiMend BA

Snippet

Sponsor: Collagen Matrix | Conditions: Spinal Disease, Degenerative Disc Disease | Status: RECRUITING